A hundred and sixty female white mice, each weighing 35-40 g, were used in this study. The animals were assigned into eight groups as one control group and 7 experimental groups. Groups 2, 3 and 4 were administered N-acetylcysteine (NAC), proanthocyanidin and vitamin E alone, at doses of 100 mg/kg/body weight/day by intra-peritoneal, oral route and, intramuscular, respectively. Group 5 was administered a single dose of cyfluthrin (100 mg g/kg/body weight ∼1/3LD50) by oral, whereas Groups 6, 7 and 8 were given cyfluthrin+NAC, cyfluthrin+proanthocyanidin and cyfluthrin+vitamin E, at the same dose, respectively. The administration of the drugs was initiated following the administration of cyfluthrin, and continued until the end of the seventh day of the study. Blood samples were collected from each group, 24 h, and 3, 7 and 9 days after the administration of cyfluthrin for the assessment of blood malondialdehyde (MDA) levels and superoxide dismutase (SOD) and catalase (CAT) activities. According to the data obtained, compared to the control group, increase in the plasma MDA level of the group administered cyfluthrin alone, and decrease in erythrocyte SOD activities in some periods and CAT activities in all periods were determined. On the other hand, especially, MDA levels and CAT activities were observed to move closer to values of the control group, in the groups that were administered NAC, proanthocyanidin and vitamin E in addition to cyfluthrin. In other words, in most periods, decrease in plasma MDA levels, and increase in erythrocyte CAT and SOD activities were observed in comparison to the group administered cyfluthrin alone. Statistical analyses demonstrated significant differences to exist between the groups on the third, seventh and ninth days with respect to plasma MDA levels, and the third and ninth days with respect to erythrocyte SOD and CAT activities (P < 0.05). However no significant difference was demonstrated in any of the periods in the groups that were administered NAC, proanthocyanidin and vitamin E alone in comparison to the control group (P > 0.05). In view of the parameters examined, animals were concluded to be affected by cyfluthrin and the administration of the three compounds at the indicated doses and for the indicated periods were considered to alleviate the adverse effects of cyfluthrin partly throughout the study period. © 2006 Elsevier Inc. All rights reserved.